Cultivators express interest in seeds over clones

08:50 |

November 18, 2024 l Sign Me Up

Add the Science Symposium to your MJBizCon ticket

Cannabis cultivators express interest in seeds over clones

Photo by creativefamily / stock.adοbe.cοm

When Mario Guzman, the creator of cannabis genetics Gelato and Sunset Sherbert, travels to Europe for events, he looks forward to meeting up with longtime friends and exchanging seeds.

"All of our global friends come, and we share genetics and talk about what we're all planting for the following year," Guzman told MJBizDaily during a recent phone call.

He likens the experience to the seed market that has existed for decades in the coffee shops of Amsterdam.

"They were really the culture of it: the passionate backbone of all seed sales in Europe," Guzman said of Amsterdam-based growers and seed breeders, adding that until the medical marijuana market got a toehold in the United States, legacy growers brought seeds from outside the U.S. that later became the bedrock of today's regulated market. Read story >

Q U A L I T Y C O N T R O L

California cannabis recalls highlight importance of decontamination

In August, California's Department of Cannabis Control issued five marijuana product recalls that cited the presence of aspergillus, bringing the total number of such recalls to 21 for 2024.

This sharp rise in mold-related recalls – particularly for aspergillus – has cannabis cultivators across the state on high alert.

For marijuana cultivators, a product recall can be catastrophic – not only in terms of lost revenue but also in terms of damaged public perception. Read story >

W E B I N A R

With recent shifts in federal policy, cannabis businesses face an unprecedented opportunity to challenge 280E. Despite the IRS's warnings of increased enforcement against companies that do not comply, many cannabis companies are taking bold action by amending tax returns and refusing to reduce deductions.

Join MJBizDaily and Justin Botillier, CEO of Calyx CPA on Thursday, Nov. 21 at 2:00 p.m. ET for a free webinar that will dive into:

A historical overview of the cannabis industry's strategies to mitigate the effects of 280E.
The justifications being used by MSOs like Trulieve to amend tax returns and reclaim disallowed deductions.
The lawsuit pursued by Verano Holdings and Canna Provisions and its implications if successful.
Recent Supreme Court actions that undermine the applicability of the CSA and, therefore, 280E.
The implications of the imminent reclassification of cannabis to a Schedule III substance.
The statutes of limitations for amending returns and the potential risks of taking bold actions.

Register Now

R E S C H E D U L I N G

DEA picks 25 to participate in marijuana rescheduling hearing

The U.S. Drug Enforcement Administration has contacted 25 "designated participants" to testify at a Dec. 2 hearing about marijuana rescheduling, according to documents obtained by MJBizDaily.

Before marijuana can be moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, DEA Administrator Anne Milgram ordered that the matter go before an administrative law judge. Read story >

C O N F E R E N C E

MJBizCon Agenda now LIVE!

MJBizCon's Conference Agenda has been announced, including this year's State of the Industry. This session brings together the MJBizDaily Editorial team alongside Marcia Pledger, Florida State Chapter Director of Minorities for Medical Marijuana in a panel moderated by Kate Lavin, Editorial Director of MJBiz. The annual must-attend State of the Industry presentation is titled, The State of Cannabis in 2024: Achieving Success While Navigating Industry Upheaval.

The science-focused content at MJBizCon is expanding to combine the best of The Emerald Conference for a powerhouse scientific event on Dec. 3 at the Las Vegas Convention Center.

The MJBiz Science Symposium powered by The Emerald Conference will feature 7 sessions of must-attend session content. Scroll down for a sneak peek and check our full Agenda for more updates.

Tickets to the Science Symposium can be added to any MJBizCon pass. Register now >

SCIENCE SYMPOSIUM

Breeding Technology for the Next Evolution of Cannabis Genetics

Tues, Dec. 3 • 10:35 - 11:15 a.m.

Cannabis breeding is entering a new era, driven by cutting-edge technologies that are revolutionizing how we understand and develop genetics. This session will explore the latest advancements in breeding technology, including CRISPR gene editing, marker-assisted selection and advanced phenotyping. Attendees will learn how these innovations are unlocking new possibilities for creating cannabis strains with targeted cannabinoid profiles, disease resistance and improved environmental adaptability.

Alisha Holloway

Chief Scientific Officer, Phylos

As the Chief Scientific Officer at Phylos, Alisha leads the R&D and Breeding groups that focus on the discovery and implementation of genetic markers for high-value traits, and the development of new cannabis varieties via classical and marker-assisted breeding. Alisha received a PhD in Biology from the University of Texas at Austin. She holds an assistant professor appointment at UCSF, and was the founding director of the Gladstone Institutes Bioinformatics Core Facility.

SCIENCE SYMPOSIUM

Rolling with Science: Perfecting the Joint and Vaporizing the Competition

Tues, Dec. 3 • 11:20 - 12:00 p.m.

The cannabis market is booming, with pre-roll sales leading the charge at a staggering 40% year-over-year growth, now exceeding $1.2 billion. Infused joints, in particular, dominate the sector, making up 20% of all pre-roll sales. Despite their popularity, surprisingly little research exists on how pre-rolls actually perform. What influences their burn, potency, and overall experience? Critical factors like particle size and humidity remain largely unexplored.

Dr. Markus Roggen

Founder, Controlled Chemistry

Dr. Markus Roggen is founder of Controlled Chemistry, an academic joint venture licensed for cannabis research focused on AI for process optimization and next generation analytical chemistry. Controlled Chemistry is the rebirth of Delic Labs / Complex Biotech Discovery, reorganized towards Catalytic Theory Crafting and Conceptual Seedbed Studies.

SCIENCE SYMPOSIUM

The Differences Between Cannabis Decontamination and Remediation: Analyzing the Latest Research

Tues, Dec. 3 • 9:50 - 10:30 a.m.

This session will explore the critical distinctions between cannabis decontamination and remediation. The panelists will provide a comprehensive analysis of the latest research and methodologies used to ensure the safety and quality of cannabis products. The panelists will share actionable insights and knowledge to ensure the highest standards of product integrity and consumer safety. This session will contribute to the ongoing efforts to promote product excellence in the industry.

Willie McKinney

CEO & Founder, McKinney Regulatory Science Advisors

Dr. Willie McKinney is an established regulatory and inhalation toxicology expert with over two decades of research, product development and regulatory strategy experience in the Consumer-Packaged Goods industry. He leverages his extensive background, including his previous role on the FDA's Tobacco Product Scientific Advisory Committee to guide clients through multiple constantly evolving regulatory landscapes.

P S Y C H E D E L I C S

Get the latest in psychedelics science at the reMind Business Forum

CS_4805_2024_reMind_Emcee Graphic 1200x630 copy

The reMind Psychedelics Business Forum is where the most important conversations surrounding psychedelics take place.

This year's event welcomes a diverse lineup of sessions and speakers, with Ricardo Baca, CEO & Co-Founder of Grasslands: A Journalism-Minded Agency as this year's Emcee.

As a 20-year veteran journalist and drug policy architect, Ricardo will provide key insights and relevancy to the series of topics discussed at only at reMind.

Mark your calendars and secure your spot at the reMind Psychedelics Business Forum today! Learn More >

Don't make decisions without the Facts!

What does rescheduling mean for your business? Use insights from the MJBiz Factbook to plan your next move:

Measure market opportunity.
Plan for operation expansions.
Forecast detailed financials and investments.
Scope out state and national growth areas.
Define successful business strategies.
Avoid costly missteps and more!

Become a Factbook Member

R E S O U R C E S

Breaking Through: Four Brands Share Blueprints for Profitability

MJBizMagazine Nov/Dec issue: Breaking Through to Profitability
REGISTER! Fuel Your Fire at MJBizCon, Dec. 3-6 – Get tickets!
Gain new leads + land big deals at MJBizCon – Book a booth
Make informed decisions with MJBiz Factbook – Get data
MJBiz Free Cannabis 101 Course – Sign up and start learning
MJBizDaily Reports and Buyers Guides – Download
MJBiz Media Kit – Advertise with us

MJBiz Science provides new findings in cannabis testing, genetics, pharmaceuticals and more for MJBizDaily, the leading resource for the cannabis industry, cited by The Wall Street Journal, Forbes and Harvard Business Review. MJBiz also produces the No. 1 cannabis business conference, MJBizCon.

Share MJBiz Science

Forward this email to friends and colleagues to keep them on the up and up with the latest cannabis business news and insights from MJBiz.

MJBizCon 2024

Dec. 3-6, 2024 l Las Vegas | Learn More